/lifesciences?utm_source=rss&utm_medium=rss&utm_campaign=section Latest articles for: Life Sciences Copyright 2025 极速赛车. en-US Tue, 17 Jun 2025 16:39:48 +0000 /lifesciences/articles/2354390?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2354390 Twenty-one New Jersey-based plaintiffs who claim they suffered permanent vision loss after taking the blockbuster drugs Ozempic and Wegovy are seeking to consolidate their lawsuits as multicounty litigation against drugmaker Novo Nordisk, citing a growing body of scientific evidence linking the medications to a rare and irreversible eye condition. Tue, 17 Jun 2025 16:35:01 +0000 /lifesciences/articles/2341634?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2341634 As discussed at a recent panel at Texas A&M, artificial intelligence will not erase the human element of adjudication in the next 10 to 20 years, but it will drive efficiencies that spur private arbiters to experiment, lead public courts to evolve and force attorneys to adapt, says Christopher Seck at Squire Patton. Tue, 17 Jun 2025 15:47:53 +0000 /lifesciences/articles/2354279?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2354279 Surgery Partners, a short-stay surgical facility owner, said on Tuesday it has ended talks with Bain Capital regarding a nearly $3.3 billion take-private proposal, saying it sees a stronger future as a public company. Tue, 17 Jun 2025 13:53:55 +0000 /lifesciences/articles/2354041?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2354041 A Canadian artificial intelligence company聽focusing on medical information has聽asked a Massachusetts federal judge to toss out a recent trade secrets lawsuit, saying the complaint is an attempt to thwart competition based solely on speculation. Tue, 17 Jun 2025 13:16:16 +0000 /lifesciences/articles/2354260?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2354260 Kirkland-advised Eli Lilly and Co. said Tuesday it will acquire Paul Weiss-advised Verve Therapeutics in a deal worth up to $1.3 billion, continuing its push into next-generation genetic medicines for heart disease. Tue, 17 Jun 2025 11:48:39 +0000 /lifesciences/articles/2353327?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2353327 As judges issue sanctions for courtroom incivility, and state bars advance formal discipline rules, trial lawyers must understand that the difference between zealous advocacy and unprofessionalism is not just a matter of tone; it's a marker of skill, credibility and potentially disciplinary exposure, says Nate Sabri at Perkins Coie. Mon, 16 Jun 2025 23:05:55 +0000 /lifesciences/articles/2354126?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2354126 A physician has agreed to plead guilty to helping supply the ketamine that killed "Friends" star Matthew Perry, according to a plea agreement filed in California federal court Monday. Mon, 16 Jun 2025 22:52:15 +0000 /lifesciences/articles/2354000?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2354000 Spinal device maker Life Spine slapped its founder with a civil suit in Illinois state court Friday accusing him of embezzling millions of dollars from the company through fraudulent credit card charges for motorsports, a lavish Mexico vacation for his family, customized golf clubs, jewelry and a Porsche for his wife.聽 Mon, 16 Jun 2025 21:12:34 +0000 /lifesciences/articles/2354110?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2354110 Delaware's Court of Chancery this past week sought answers in the high-stakes battle over the constitutionality of newly enacted Delaware corporation law amendments, which will hitch a ride to the state's Supreme Court via a suit contesting a $117 million acquisition of Clearway Energy Inc. by its majority shareholder. Mon, 16 Jun 2025 21:06:49 +0000 /lifesciences/articles/2353835?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2353835 Monsanto confirmed Monday that it has settled a Texas man's Roundup cancer lawsuit shortly before closing arguments in the trial were set to begin. Mon, 16 Jun 2025 19:06:15 +0000 /lifesciences/articles/2353762?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2353762 The Federal Circuit on Monday reversed a Florida federal court's decision that ThermoLife falsely promoted amino acid products used in supplements and engaged in unfair competition, but backed a sanctions award over a licensing agreement issue. Mon, 16 Jun 2025 18:53:42 +0000 /lifesciences/articles/2353468?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2353468 Ohio urged the Sixth Circuit to send its case accusing Express Scripts and Prime Therapeutics of driving up prescription drug prices through rebate schemes back to state court, arguing the case doesn't target any federal government work by the pharmacy benefit managers. Mon, 16 Jun 2025 16:51:01 +0000 /lifesciences/articles/2352164?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2352164 When companies must choose between initiating patent litigation in the U.S. International Trade Commission or the European Union's Unified Patent Court, the ITC may offer a few distinct advantages, but ultimately the decision requires consideration of case-specific factors, say attorneys at White & Case. Mon, 16 Jun 2025 16:49:58 +0000 /lifesciences/articles/2351793?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2351793 The time is right to amend Rule 702 of the New Jersey Rules of Evidence to align it with the recently amended Rule 702 of the Federal Rules of Evidence and clarify the standard for admissibility of expert testimony, says Timothy Freeman at Tanenbaum Keale. Mon, 16 Jun 2025 16:25:50 +0000 /lifesciences/articles/2353731?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2353731 A California hemp farm is urging a Tennessee federal court not to throw out its suit as untimely against a Tennessee sheriff's office over $3.9 million in hemp flower the farm claimed was wrongly seized and then destroyed, saying it only learned that the hemp was illegally seized at a hearing for the hemp deliveryman months afterward. Mon, 16 Jun 2025 16:14:29 +0000 /lifesciences/articles/2353632?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2353632 Supernus Pharmaceuticals, represented by聽Saul Ewing LLP, said Monday it will acquire聽Kirkland-advised Sage Therapeutics in a transaction worth as much as $795 million, strengthening Supernus' position in treating neuropsychiatric conditions and expanding its central nervous system health portfolio. Mon, 16 Jun 2025 16:10:09 +0000 /lifesciences/articles/2352907?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2352907 In recent decades, shareholders have challenged the internal affairs doctrine by bringing a series of derivative actions in New York state court on behalf of foreign corporations, but the New York Court of Appeals' recent rulings in Ezrasons v. Rudd and Haussmann v. Baumann should slow that trend, say attorneys at Cleary. Mon, 16 Jun 2025 15:36:04 +0000 /lifesciences/articles/2353699?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2353699 An attorney who has spent his entire career with Office of Inspector General for the U.S. Department of Health and Human Services, serving most recently as its chief counsel, has joined King & Spalding LLP's healthcare team in Washington, D.C., the firm announced on Monday. Mon, 16 Jun 2025 15:26:23 +0000 /lifesciences/articles/2352951?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2352951 A Massachusetts federal judge on Monday blocked the National Institutes of Health from cutting hundreds of grant programs to universities, hospitals and other organizations, saying that in his 40 years on the bench he had never seen such "palpable" racial and LGBTQ discrimination from the government. Mon, 16 Jun 2025 12:58:44 +0000 /lifesciences/articles/2353695?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2353695 Attorneys general from 55 U.S. states and territories on Monday backed Purdue Pharma's $7.4 billion deal to settle opioid injury claims against the company and the Sackler family, almost a year after the U.S. Supreme Court threw out Purdue's previous plan to end litigation over its role in the opioid epidemic.